SGLT2 Inhibitors and Stroke Risk in Patients with Type 2 Diabetes—A Systematic Review and Meta-analysis

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 165-OR
Author(s):  
MAN GUO ◽  
YONG XU
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Stroke Risk ◽  
Meta Analysis ◽  
Sglt2 Inhibitors

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis

2021 ◽  
Vol 174 ◽  
pp. 108737
Author(s):  
Thomas Karagiannis ◽  
Apostolos Tsapas ◽  
Eleni Athanasiadou ◽  
Ioannis Avgerinos ◽  
Aris Liakos ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Older People ◽  
Meta Analysis ◽  
Sglt2 Inhibitors ◽  
Receptor Agonists

scholarly journals SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

2019 ◽  
Vol 7 (11) ◽  
pp. 845-854 ◽  
Author(s):  
Brendon L Neuen ◽  
Tamara Young ◽  
Hiddo J L Heerspink ◽  
Bruce Neal ◽  
Vlado Perkovic ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Kidney Failure ◽  
Meta Analysis ◽  
Sglt2 Inhibitors

SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis

2018 ◽  
Vol 20 (8) ◽  
pp. 1977-1982 ◽  
Author(s):  
Man Guo ◽  
Jingya Ding ◽  
Jingsong Li ◽  
Jiying Wang ◽  
Ting Zhang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Type 2 Diabetes ◽  
Meta Analysis ◽  
Sglt2 Inhibitors
Sign in / Sign up

Export Citation Format

Share Document